Intelligent Bio Solutions (INBS) Non-Current Debt (2022 - 2024)
Intelligent Bio Solutions has reported Non-Current Debt over the past 3 years, most recently at $150426.0 for Q1 2024.
- Quarterly results put Non-Current Debt at $150426.0 for Q1 2024, down 68.05% from a year ago — trailing twelve months through Mar 2024 was $150426.0 (down 68.05% YoY), and the annual figure for FY2023 was $402862.0, changed.
- Non-Current Debt for Q1 2024 was $150426.0 at Intelligent Bio Solutions, down from $230969.0 in the prior quarter.
- Over the last five years, Non-Current Debt for INBS hit a ceiling of $507403.0 in Q4 2022 and a floor of $150426.0 in Q1 2024.
- Median Non-Current Debt over the past 3 years was $354548.0 (2023), compared with a mean of $344794.3.
- Biggest five-year swings in Non-Current Debt: crashed 54.48% in 2023 and later tumbled 68.05% in 2024.
- Intelligent Bio Solutions' Non-Current Debt stood at $507403.0 in 2022, then crashed by 54.48% to $230969.0 in 2023, then tumbled by 34.87% to $150426.0 in 2024.
- The last three reported values for Non-Current Debt were $150426.0 (Q1 2024), $230969.0 (Q4 2023), and $306234.0 (Q3 2023) per Business Quant data.